| 000 | 01690 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517214222.0 | ||
| 264 | 0 | _c20190621 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-018-4804-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaniels, Benjamin | |
| 245 | 0 | 0 |
_aLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016). _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cAug 2018 |
||
| 300 |
_a151-159 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadministration & dosage |
| 650 | 0 | 4 |
_aAustralia _xepidemiology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPublic Health Surveillance |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aRetreatment |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTrastuzumab _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKiely, Belinda E | |
| 700 | 1 | _aLord, Sarah J | |
| 700 | 1 | _aHoussami, Nehmat | |
| 700 | 1 | _aLu, Christine Y | |
| 700 | 1 | _aWard, Robyn L | |
| 700 | 1 | _aPearson, Sallie-Anne | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 171 _gno. 1 _gp. 151-159 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-018-4804-0 _zAvailable from publisher's website |
| 999 |
_c28367265 _d28367265 |
||